Interestingly, MYC has been shown to regulate the anti-tumor immune response in murine models of T cell acute lymphoblastic leukemia (ALL) and liver cancer by inducing the expression of CD47 and/or PD-L1 immune checkpoint molecules and recruiting TAMs, while excluding T cells among other mechanisms (151–153). Here, CD274 is linked to neoplasm.